Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Study reveals the risk factors associated with developing long Covid

Being vaccinated against Covid halves people's risk of developing long Covid, according to new research from the University of East Anglia.

23 Mar 2023

High fitness levels may reduce the risk of cardiovascular death in men with high blood pressure

High fitness levels may reduce the risk of death from cardiovascular disease in men with high blood pressure, according to a 29-year study published today in the European Journal of Preventive Cardiology, a journal of the ESC.

23 Mar 2023

Molecular mechanism involved in the development of type 2 diabetes discovered

Type 2 diabetes is a chronic disease in which the body does not produce enough insulin, or does not use it efficiently.

23 Mar 2023

Fresh produce is an increasingly popular prescription for chronically ill patients

When Mackenzie Sachs, a registered dietitian on the Blackfeet Reservation, in northwestern Montana, sees a patient experiencing high blood pressure, diabetes, or another chronic illness, her first thought isn't necessarily to recommend medication.

23 Mar 2023

Higher plasma caffeine concentrations might reduce body fat and type 2 diabetes risk

In a recent study published in the journal BMJ Medicine, researchers in the United Kingdom and Sweden investigated the probable causality of long-term serum caffeine concentrations on type 2 diabetes (T2D), adiposity, and major cardiovascular diseases (CVDs).

22 Mar 2023

Complications, pathophysiology, and treatment of type 2 diabetes differ by sex

In a recent review published in the journal Diabetologia, researchers in Austria discussed the sex-based differences in the risk factors, diagnosis, and therapeutic approaches for type 2 diabetes and associated complications to improve awareness about and management options for all diabetes type 2 patients.

22 Mar 2023

Public’s view of obesity has changed since the pandemic, survey shows

Nearly a third of Americans (29%) say COVID-19 made them more worried than ever about having obesity prompting about 28 million people to consider weight-loss methods they hadn't thought about before the pandemic began, including nearly 6.4 million thought about turning to either weight-loss surgery or taking prescription anti-obesity drugs for the first time, according to a new survey whose findings were published online in the peer-reviewed journal, Surgery for Obesity and Related Diseases.

22 Mar 2023

Childhood and adolescent obesity: time to act

In a recent review published in the journal Frontiers in Pediatrics, researchers at the Medical College of Wisconsin presented an overview of the pathophysiological mechanisms, health implications, and management options for obesity among children and adults.

21 Mar 2023

Supervised exercise training is safe and may improve quality of life for many people with heart failure

For many people who have heart failure, supervised exercise training is safe and may offer substantial improvement in exercise capacity and quality of life, even more than medications, according to a new, joint scientific statement from the American Heart Association and the American College of Cardiology.

21 Mar 2023

The high phenolic content of traditional Mexican food contributes to better health

Researchers assess the phenolic content of traditional Mexican food and its impact on health outcomes.

20 Mar 2023

Diabetes WA calls for greater recognition of diabetes impact on Aboriginal Communities

On National Close the Gap Day (Thursday 16 March), Diabetes WA is calling for greater recognition of the disproportionate impact of diabetes on Aboriginal Communities in Western Australia. Aboriginal West Australians are at far greater risk of diabetes and diabetes-related complications than any other community in the State.

20 Mar 2023

New WHO report identifies five core national targets for managing diabetes

A new report for the World Health Organization has identified five core national targets for UN member states aimed at reducing diabetes risk and ensuring that people with diabetes have equitable access to comprehensive and affordable care and prevention.

20 Mar 2023

Biomarkers that can predict long COVID symptoms

The current study offered novel insights into the different biological factors that might contribute to long COVID.

19 Mar 2023

Loss of a beta cell subset might contribute to type 2 diabetes

Multiple types of beta cells produce insulin in the pancreas, helping to balance blood sugar levels. Losing a particularly productive type of beta cell may contribute to the development of diabetes, according to a new study by Weill Cornell Medicine investigators.

17 Mar 2023

Phase 2 clinical trial investigates the effectiveness of innovative procedure to control Type 2 diabetes

More than 37 million Americans have diabetes, and approximately 90-95% have Type 2 diabetes.

16 Mar 2023

The relationship between intestinal microbiome dysbiosis and atherosclerosis

Researchers investigate the impact of intestinal microbiota dysbiosis on atherosclerotic cardiovascular disease incidence.

15 Mar 2023

How does soy consumption affect the risk of type 2 diabetes and cardiovascular diseases?

A higher intake of plant protein could effectively improve metabolic health and lower CVD mortality. Recently, scientists in China reviewed existing literature and conducted a meta-analysis to understand the association between increased soy consumption and the risk of T2D and CVDs. This review is available in the journal Nutrients.

15 Mar 2023

Higher plasma caffeine levels may reduce adiposity and risk of type 2 diabetes

A high blood caffeine level might curb the amount of body fat a person carries and their risk of type 2 diabetes, suggests research published in the open access journal BMJ Medicine.

15 Mar 2023

Long-acting GIPRA inhibits feeding and lowers body weight in mice with diet-induced obesity

The hormone glucose-dependent insulinotropic polypeptide (GIP) is considered obesogenic. In contrast, GIP receptor agonists (GIPRAs) have shown reduced feeding and body weight in an obese mouse model. Therefore, the precise effects exerted by GIP and GIPRAs remain elusive.

14 Mar 2023

Hypothalamic inflammation and obesity, study suggests a pathological mechanism

In a recent review published in the European Journal of Endocrinology, researchers discussed current research on the relationship between human obesity and inflammation of the hypothalamus.

14 Mar 2023

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Study reveals the risk factors associated with developing long Covid

High fitness levels may reduce the risk of cardiovascular death in men with high blood pressure

Molecular mechanism involved in the development of type 2 diabetes discovered

Fresh produce is an increasingly popular prescription for chronically ill patients

Higher plasma caffeine concentrations might reduce body fat and type 2 diabetes risk

Complications, pathophysiology, and treatment of type 2 diabetes differ by sex

Public’s view of obesity has changed since the pandemic, survey shows

Childhood and adolescent obesity: time to act

Supervised exercise training is safe and may improve quality of life for many people with heart failure

The high phenolic content of traditional Mexican food contributes to better health

Diabetes WA calls for greater recognition of diabetes impact on Aboriginal Communities

New WHO report identifies five core national targets for managing diabetes

Biomarkers that can predict long COVID symptoms

Loss of a beta cell subset might contribute to type 2 diabetes

Phase 2 clinical trial investigates the effectiveness of innovative procedure to control Type 2 diabetes

The relationship between intestinal microbiome dysbiosis and atherosclerosis

How does soy consumption affect the risk of type 2 diabetes and cardiovascular diseases?

Higher plasma caffeine levels may reduce adiposity and risk of type 2 diabetes

Long-acting GIPRA inhibits feeding and lowers body weight in mice with diet-induced obesity

Hypothalamic inflammation and obesity, study suggests a pathological mechanism

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in